Loading...

Gregory Simpson

TitleAssociate Professor
SchoolUCSF School of Medicine
DepartmentDean's Office
Address401 Parnassus Ave.
San Francisco CA 94143
Phone559-499-6500
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Franklin Road Academy1996Salutatorian
    University of North Carolina at Chapel Hill1996  - 2000Honors Student
    Recipient2006Al Gore Scholarship
    Alpha Omega Alpha2006Member

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Training Attentional Awareness and Control in ADHD
    NIH R43MH101924Aug 2, 2013 - Jun 30, 2015
    Role: Principal Investigator
    Neurophysiological Attention Test (NAT) for Objective Assessment of ADHD
    NIH R44MH099709Apr 3, 2013 - Aug 31, 2018
    Role: Principal Investigator
    Neurophysiological Attention Test (NAT)for Objective Assessment of ADHD
    NIH R43MH099709Apr 3, 2013 - Mar 31, 2016
    Role: Principal Investigator
    Network for the Study of Brain Systems and Dynamics
    NIH R01NS045171Sep 30, 2002 - Jun 30, 2008
    Role: Principal Investigator
    Computational Anatomy and Multidimensional Modeling
    NIH P41RR013642Sep 30, 1998 - Sep 6, 2012
    Role: Co-Investigator
    DYNAMICS AND CEREBRAL SOURCES OF ATTENTIONAL PROCESSES
    NIH R01NS027900Jul 1, 1990 - Apr 30, 2006
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Simpson G, Cohen SF. Pruritic scaly plaques in a 75-year-old Hispanic man. Enterobius vermicularis (pinworm). Arch Dermatol. 2012 Sep 1; 148(9):1073-8. PMID: 22986865 .
    2. Shroff A, Simpson G .
    3. Roffwarg D, Brown A, Alisangco M, Davis LS, Simpson G .
    4. Paul Haun, Gregory L. Simpson, Joshua Wharton, Daniel J. Sheehan. “Acute mental status change in an Immunocompromised patient” Clinical Infectious Diseases. 2010; 50:395-396. .
    5. Parachuru LV, Simpson G, Davis, LD. “Secondary Syphilis” 56th Annual Zola Cooper Seminar 2009 accepted for publication. .
    6. Kannan, Swati; Simpson, Gregory L; Sheehan, Daniel J; Lesher, Jack L Jr. “Giant verrucous nodules in a patient with tuberculosis” The American Journal of Dermatopathology. 31(6):591-593, August 2009. .
    7. Yentzer BA, Yelverton CB, Simpson G, Simpson JF, Hwang W, Balkrishnan R, Feldman SR.“Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis”Dermatology Online Journal. 2009 Apr 15; 15(4):1. .
    8. Simpson G, Lesher JL, Sheehan DJ. “Sarcoidosis” 55th Annual Zola Cooper Seminar 2008 .
    9. Simpson G, Davis LS, Sheehan DJ. “Epidermolysis Bullosa Acquisita” Southeastern Consortium 10/08 .
    10. Simpson G, Lesher JL. “Necrobiosis Lipoidica” Southeastern Consortium 10/08.
    11. Simpson G, Davis LS, Guill M. “Sarcoidosis” Southeastern Consortium 10/08 .
    12. Simpson G, Lesher JL. “Verrucous Sarcoidosis” Southeastern Consortium 10/08 .
    13. Simpson G, Sheehan DJ. “Sarcoidosis” Southeastern Consortium 10/08 .
    14. Alan L. Levy, Gregory Simpson, Robert B. Skinner, “Medical Pearl: Circle of Desquamation—A clue to the diagnosis of folliculitis and furunculosis caused by Staphylococcus aureus” /> JAAD, December 2006 (Vol. 55, Issue 6, Pages 1079-1080) .
    15. Simpson G, Yelverton CB, Rittenberg S, Feldman SR “Do utilization management controls for phototherapy increase the prescription of biologics?” Journal of Dermatology Treatment. 2006; 17(6):359-61. Review.
    16. Simpson G,Koo, JY. “Bath PUVA Revisited: Advantages, Disadvantages and Techniques” Psoriasis Forum, Spring 2006 Vol. 12, No 1. .
    17. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson G, Cotecchia S, Rokosh DG, Grossman W, Foster E, Simpson PC (2003). “The a1A/C- and a1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse” Journal of Clinical Investigation 111: 1783-1791 .
    18. O'Connell TD, Swigart PM, McCloskey DT, Simpson G, Baker AJ, Simpson PC. "Double knockout of the _aA/C and_a1B-adrenergic receptors reduce heart and myocyte_b-adrenergic response despite an increase in b-adrenergic receptors" Circulation 108:IV-1.
    Back to TOP